From	To	Speaker	Title	Country
09:30	10:00	Silvio Perea	CIGB-300: "From bench to clinic"	Cuba
10:00	10:30	Mahvash Tavassoli	Novel strategy for the expression and delivery of therapeutic proteins	United Kingdom
10:30	11:00	Jens Hoffmann	Using Systems Biology Approaches for Profiling of Novel anti-cancer drugs	Germany
11:00	11:30	Harish Padh	Designing Therapeutic Nanoparticles for Drug Targeting Using Receptor Mediated Endosomal Route	India
11:30	12:00		Break
12:00	12:25	Iraldo Bello	HeberPAG, a new stabilized pharmaceutical formulation based on IFNs for the treatment of Cancer	Cuba
12:25	12:50	Dipak K. Banerjee	Glycotherapeutic for Treating Breast Cancer	Puerto Rico
12:50	13:15	Yasser Perera	Anticancer peptide CIGB-300 targets the oncoprotein B23/ nucleophosmin, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity	Cuba
13:15	13:40	Marketa Urbanova	Transcriptional analysis of head and neck squamous cell carcinoma.	Czech Republic
13:40	14:05	María del Carmen Abrahantes	CIGB370: a novel antineoplastic agent derived from infection-mediated tumor regression	Cuba

From	To	Speaker	Title	Country
09:30	10:00	Luca Bini	Proteomics and human diseases	Italy
10:05	10:35	Anne-Claude Gavin	Biochemical approaches to biomolecular networks	Germany
10:40	11:10	Jacques Colinge	Data integration over protein interaction networks	Austria
11:15	12:00		Break
12:00	12:30	Peter Roepstorff	Recent advances in determination of protein post translational modifications	Denmark
12:35	13:05	Juan J. Calvete	Venoms, Venomics, Antivenomics	Spain
13:10	13:30	Arielis Rodriguez	Proteomic profile regulated by the antitumoral peptide CIGB-300	Cuba
13:35	13:55	Jeovanis Gil	Proteomic study of Neisseria meningitidis OMVs	Cuba

From	To	Speaker	Title	Country
09:30	10:00	Jean Dubuisson	Hepatitis C virus and the glycan shield.	France
10:00	10:30	Birke Tews	Molecular and biochemical characterization of EWI-2wint – a natural inhibitor of HCV entry	France
10:30	11:00	Fons Bosman	Characterization study of the hepatitis C envelope protein E1 expressed in the methylothropic yeast Hansenula polymorpha	Belgium
11:00	11:30	Francois Penin	Structure and interaction of hepatitis C virus proteins with host cell membranes	France
11:30	12:00		Break
12:00	12:30	John Hiscott	Sensing and Responding to Hepatitis C Virus Infection through RIG-I like Receptors.	Canada
12:30	13:00	Francisco García Cózar	Rationale for Immunotherapy in Hepatitis C Virus.	Spain
13:00	13:30	Santiago Dueñas-Carrera	DNA-based immunotherapy against HCV infection, facts and challenges	Cuba

From	To	Speaker	Title	Country
09:30	09:55	Giuseppe Novelli	Advances in genetics and therapy of Neuromuscular Disorders	Italy
09:55	10:20	Tatiana Zaldívar	Multidisciplinary management in Motor Neurone Disease : Cuban experience	Cuba
10:20	10:45	Giselle Pentón-Rol	T-cell immunoregulation in Multiple Sclerosis. Effect of C-Phycocyanin and its combination with alpha Interferon	Cuba
10:45	11:10	Carsten Werner	Heparin-starPEG hydrogels to enable cell replacement therapies for neurodegenerative diseases	Germany
11:10	11:35	Jorge Berlanga	Therapeutic effect of the combined use of Growth Hormone Releasing Peptide-6 and Epidermal Growth Factor in an axonopathy model	Cuba
11:35	12:00		Break
12:00	12:25	Linda Greensmith	Developing novel therapeutic strategies in models of Amyotrophic Lateral Sclerosis (ALS)	United Kingdom
12:25	12:50	Denise A. Figlewicz	ALS: Making the connection between disease mechanisms and therapeutic strategies	Canada
12:50	13:15	Michael Strong	The evidence for amyotrophic lateral sclerosis (ALS) as a disorder of altered RNA metabolism	Canada
13:15	13:40	Giancarlo Logroscino	ALS epidemiology: a model for the study of neurodegenerative disease	Italy
13:40	14:05	Stanley H. Appel	The Role of Immunomodulation in the Pathophysiology of ALS	USA

From	To	Speaker	Title	Country
09:30	10:00	Isis Torréns	CIGB-228 as a therapeutic HPV vaccine candidate	Cuba
10:00	10:30	Rosella Franconi	Plant-derived vaccines against HPV-associated cancers	Italy
10:30	11:00	Pidder Jansen-Dürr	Antibodies to high-risk HPV E7 oncoprotein in cervical cancer screening	Austria
11:00	11:30	Eddy Bover Fuentes	Preclinical and clinical evaluation of a gonadotrophin based vaccine candidate in the treatment of prostate cancer	Cuba
11:30	12:00		Break
12:00	12:30	Yannick Jacques	RLI, an improved version of Interleukin-15 with high therapeutic potential in cancer	France
12:30	13:00	Luis Enrique Fernández	VSSP and the Revised Concept of Cancer Vaccines	Cuba
13:00	13:30	Tim Meyer	Combining radioimmunotherapy with vascular disruptive agents. From bench to bedside.	United Kingdom
13:30	14:00	Pedro Camilo Rodriguez	Therapeutic use of CIMAvax EGF vaccine in the treatment of non small cell lung cancer patients.	Cuba

From	To	Speaker	Title	Country
09:30	09:55	David Goldstein	Rare and common variants in human disease	USA
09:55	10:20	Harish Padh	Pharmacogenomics: Correlation between phenotype and genotype in Indian population	India
10:20	10:45	Marc Via Garcia	The Importance of Population Genetics in Biomedical Research and Clinical Practice: Lessons from the Genetics of Asthma in Latino Americans (GALA) Study	Spain
10:45	11:10	Ola Soderberg	Protein interaction profiles, a venue  for understanding the consequences of genetic alterations.	Sweden
11:10	11:35	Sheng T. Hou	An integrated, functional genomics approach to identify target genes of neuronal death caused by stroke	Canada
11:35	12:00		Break
12:00	12:25	Harald Seitz	DNAzyme as alternative detection tool for microarrays	Germany
12:25	12:50	Vladimir Titorenko	Using functional proteomics and lipidomics for the identification of novel anti-aging drugs and studying the molecular mechanisms underlying their ability to extend longevity	Canada
12:50	13:15	Junsong Han	The Whole Genome Methylaiton Profile of Hepatocellular Carcinoma and Biomarkers	China
13:15	13:40	Adrienne D. Cox	Kinases and GTPases at the crossroads: An unconventional approach to molecular therapeutic targeting of oncogenic Ras via the Ras-Ral-AuroraA pathway	USA
13:45	14:05	Channing J. Der	Ras superfamily small GTPases: the next wave of targets for anti-cancer drug discovery?	USA

From	To	Speaker	Title	Country
09:30	09:55	Michel Ovize	Protecting the heart by ischemic postconditioning	France
09:55	10:20	Guido Tarone	Melusin, a new player in cardiac hypertrophy: possible translational applications in gene therapy	Italy
10:20	10:45	Ariana García	Angiogenic gene therapy for ischemic vascular disease	Cuba
10:45	11:10	Danay Cibrian	CIGB500- A peptide with cardioprotective effects	Cuba
11:10	11:35	Claude Julien	Blood pressure variability: a new therapeutic target	France

From	To	Speaker	Title	Country
11:50	12:15	Verena Lucila Muzio	Prevention of hepatitis B with monovalent and combination vaccines in Cuba	Cuba
12:15	12:40	Carla Montesano	HBV infection in Africa and prospective for preventing HBV infection in newborn	Italy
12:40	13:05	Marie Louise Michel	A novel strategy to overcome immune tolerance during persistent hepatitis B virus infection	France
13:05	13:30	Julio Cesar Aguilar	NASVAC: a new vaccine candidate for chronic hepatitis B immunotherapy.	Cuba
13:30	13:55	Lucyna Cova	Evaluation of novel therapeutic approaches against chronic hepatitis B in the Duck Hepatitis B Virus (DHBV) infection model.	France

From	To	Speaker	Title	Country
09:30	10:00	Georg Büldt	Proton pumping and signal transduction across membranes by retinal proteins – a study by X-ray crystallography and spectroscopy	Germany
10:00	10:30	Bernard Maigret	The protein-protein docking challenge	France
10:30	11:00	Guy Dodson	Insulin's structural and biological behaviour when mutated with D&L sidechains at the invariant glycine B8.	United Kingdom
11:00	11:30	Philip Evans	The recognition of endocytic cargo	United Kingdom
11:30	12:00		Break
12:00	12:30	Eleanor Dodson	What can crystal structures tell us about their ligands?	United Kingdom
12:30	13:00	Martin Noble	Understanding and targetting the CDK gene family	United Kingdom
13:00	13:30	Andrey Lebedev	Mechanism of DNA translocation through the bacteriophage portal protein	United Kingdom

From	To	Speaker	Title	Country
09:30	10:00	Marta Ayala	Antiangiogenic Therapeutic Cancer Vaccine	Cuba
10:00	10:30	Farzin Farzaneh	Tumour cells, antigen loaded dendritic cells and direct peptide vaccination mediated induction of tumour immunity	United Kingdom
10:30	11:00	David Klatzmann	Manipulating suppressor T cells for cancer immunotherapy: clinical results	France
11:00	11:30	Lincidio Pérez	Phase I Clinical Trial of the 131I-Labeled anti-CEA CIGB-M3 Multivalent Antibody Fragment	Cuba
11:30	12:00		Break
1200	12:30	John Hiscott	Manipulating the Innate Immune Response to Augment Oncolytic Virus Therapies	Canada
12:30	13:00	Rolando Pérez	The role of cancer immunotherapy in the control of the advanced disease: an emergent paradigm.	Cuba
13:00	13:30	Luis Alvarez-Vallina	In situ expression of recombinant antibodies	Spain
13:30	14:00	Belinda Sanchez	EGFR-based active specific immunotherapy for the treatment of epithelial tumors	Cuba

From	To	Speaker	Title	Country
09:30	09:50		Introduction
09:50	10:15	Alexander I. Archakov	Analytical nanotechnology in biology and medicine	Russia
10:20	10:45	Gerardo Guillén	Virus Like Particles as a vaccine antigens and immunopotentiators	Cuba
10:50	11:15	Victor A. Bykov	Methods of nanodiagnostics for biological and medical applications based on scanning probe technology	Russia
11:20	11:45		Break
11:45	12:10	Vadim Govorum	Microfluidic device and bacterial sensors	Russia
12:15	12:40	Gustav Borghs	Interfacing neurons with Si micro-electronics	Belgium
12:45	13:10	Yury Ivanov	Optico-Acoustic Nanobiosensor for the Registration of Protein Complexes	Russia
13:15	13:40	Sedva Senel	Applications of chitosan in mucosal vaccination	Turkey
13:45	14:10	Sergey Pushko	Actual techniques of atomic-force microscopy for metrological visualization of nanoobjects	Russia

From	To	Speaker	Title	Country
09:30	09:55	Frederic Tangy	The measles vaccine, an old powerful tool to prevent new diseases.	France
09:55	10:20	Enrique Iglesias	A Novel Multiantigenic vaccine candidate against HIV-1	Cuba
10:20	10:45	Thomas Kariuki	African Non-human Primates: Role in Preclinical trials of HIV Vaccines	Kenya
10:45	11:10	Romano Silvestri	Development of new generation anti-HIV agents	Italy
11:10	11:35	WG. Forssmann	Development of the new HIV-anchoring inhibitor VIR-576: from discovery to clinical application	Germany
11:35	12:00		Break
12:00	12:25	Ludger Ständker	Discovery of novel endogenous modulators of viral infection	Germany
12:25	12:50	Jerome Pugin	MD-2, the acceptor molecule of the LPS receptor complex	Switzerland
12:50	13:15	Camille Locht	Pertussis / tuberculosis: a same vaccine strategy for two different diseases.	France
13:15	13:40	Marcel Thalen	Whooping cough: a re-emerging disease	Netherlands

From	To	Speaker	Title	Country
09:30	09:55	Keith Mitchelson	Microarray applications in molecular diagnostics.	China
09:55	10:20	Moises Delgado	qPCR Methylation-Sensitive High Resolution Melting Analysis for the Detection of Early Stage Associated Carcinogenesis	Panama
10:20	10:45	Steve Oglessbee	Genomic Accuracy of Immortalized Human B-cells from Initial Isolation through Long Term in vitro Culture	USA
10:45	11:10	Timothy Caulfield	Personal Genomics, Direct-to-Consumer Testing and Health Care Systems	Canada

From	To	Speaker	Title	Country
11:50	12:15	Johannis P. Kamerling	The application of neoglycopeptides for sensitive SPR biosensors	Netherlands
12:15	12:40	Daryl Fernandes	A QbD (Quality by Design) Approach to Comparability of Biopharmaceutical Glycosylation	United Kingdom
12:40	13:05	Chun-Ting Yuen	Glycoprotein glycan analysis: results of an international comparative study	United Kingdom
13:05	13:30	José Cremata	The goat mammary gland as a bioreactor for the production of recombinant glycoproteins: N-glycosylation features	Cuba
13:30	13:55	Patrice Lerouge	Exploring microalgae as cell factory for the production of therapeutic proteins	France
13:55	14:20	Johannis P. Kamerling	Carbohydrate-mediated cell recognition in marine sponge cells	Netherlands